ArticleThrombosis journal2026
Sepsis induced coagulopathy (SIC): is it monolithic?
Article in Thrombosis journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
introductionSepsis-induced coagulopathy (SIC) is known to be linked with an increased mortality of sepsis.
methodsWe designed this study to investigate whether there is heterogeneity in the clinical manifestations of SIC between cases with international normalized ratio (INR) as the dominant factor and those with platelet (PLT) as the dominant factor. In this survey, 1421 SIC patients admitted to Peking Union Medical College Hospital were enrolled. External verification was conducted using data from 4732 SIC patients in the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. According to the difference of INR and PLT, SIC was divided into four subtypes: SIC-severe (PLT < 100 and INR > 1.4), SIC-INR (PLT ≥ 100 and INR > 1.4), SIC-PLT (PLT < 100 and INR ≤ 1.4), and SIC-mild (100 ≤ PLT < 150 and 1.2 < INR ≤ 1.4). MAIN
resultsThe incidence of SIC in sepsis patients was 48.70% (1421/2918). Compared with the SIC-INR group, the SIC-PLT group had shorter activated partial thromboplastin time, lower fibrinogen levels, lower lactate levels, and lower blood glucose levels (P < 0.05). Regarding liver function, compared to the SIC-INR group, the SIC-PLT group exhibited lower levels of total bilirubin, direct bilirubin, and alanine aminotransferase (P < 0.05). Concerning kidney function, the proportion of patients receiving continuous renal replacement therapy support in the SIC-PLT group was lower than that in the SIC-INR group (P < 0.05). There was no statistically significant difference in SOFA total score between the SIC-INR group and the SIC-PLT group after deducting the coagulation system score. In terms of outcomes, there were no statistically differences in costs and mortality between the SIC-INR and the SIC-PLT group, but the SIC-PLT group had shorter duration of mechanical ventilation and hospital stays after diagnosis of sepsis than the SIC-INR group (P < 0.05). Data from the MIMIC-IV database further corroborate there was heterogeneity between the SIC-INR group and the SIC-PLT group. The incidence rate of DVT in the SIC-PLT group was significantly lower than that in the SIC-INR group (P < 0.05).
conclusionsSIC with PLT change as the dominant factor and SIC with INR change as the dominant factor exhibited significant heterogeneity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.